This workflow automates the high-volume, manual bottleneck of redacting PHI from clinical documents, a prerequisite for research and external AI collaboration. It directly reduces legal risk and operational cost by replacing slow, error-prone human review with a scalable pipeline. The business value comes from unlocking trapped data assets for secondary use—accelerating research timelines and improving model training data quality—without exposing the health system to compliance violations or breach penalties.




